Sector: Pharmaceuticals

The US Court of Appeals for the Federal Circuit enjoined the defendant from marketing a particular configuration of medical device filters without clear source-identifying indicia.

25 November 2022

Featured in Stock market performance

Stock markets rebound, with energy brands the top performers, but adidas' share price suffers from Kanye split.

24 November 2022

Featured in Physical marketplace counterfeit hotspots

In this update from our series on marketplaces around the globe that are reportedly notorious for being counterfeit havens, we head to Pakistan.

16 November 2022

The judgment is significant as it explains how the BMS conditions established by the CJEU should be applied to rebranding in parallel import cases.

16 November 2022

In our latest round-up, we look at the INFORM Consumers Act moving towards passage in the US House, Continental Tires China being awarded $643,000 in damages in China, and much more.

15 November 2022

Confirmed partners include Amazon, Carousell, Indiamart, Interpol, JD, Lazada, Mastercard and Meta, with the Pharmaceutical Security Institute driving the initiative.

14 November 2022

The fact that the defendant started the sanitary authorisation process in 2015 - a year after the opposition was filed - did not go unnoticed by the court.

14 November 2022

With the growing risk of scams on Twitter, IP professionals are being urged to increase their monitoring of the social platform to find and report newly verified accounts impersonating major brands.

11 November 2022

A crowded Class 5 requires new approaches to the challenges associated with selecting and clearing pharmaceutical trademarks in the United States.

03 November 2022

In this dispute over the mark EUCALIN for nutritional supplements, the Trademark Trial and Appeal Board has held that the opponent had failed to prove that the applicant had abandoned the mark with an intent not to resume use.

02 November 2022